Please Note: There is no Medicare information on our corporate website. Please select a specific contract in the 'Search Within' box for Medicare related information.
© 2021 Palmetto GBA, LLC
We frequently update our articles to reflect the latest changes and updates to Medicare, and strongly recommend you visit this article at link below to confirm you have the latest version.
Printed Date: 9/22/2015
CMS will restart the RCD following the pause for COVID-19. Home Health claims in all demonstration states with billing periods on or after August 31, 2020, will be subject to review under the requirements of the choice selected.
RCD Cycle 1 for providers in the state of Texas has been updated due to the COVID-19 (PDF, 54 KB) pause. Cycle 1 began on March 2, 2020, and paused after one month. Recently, Palmetto GBA communicated that the remaining five months of the Cycle would begin on August 31, 2020 and end on January 31, 2021. After considering additional stakeholder feedback, CMS has determined that Cycle 1 will now end on September 30, 2020. Affirmation and Claim Approval rates will be calculated based on review decisions made between March 2, 2020, and September 30, 2020. Palmetto GBA will communicate Cycle 1 results to all providers no later than October 31, 2020.
All PCR decision during the pause will be included in the Cycle 1 affirmation rates.
Palmetto GBA will conduct postpayment review on claims subject to the demonstration that were submitted and paid during the pause. Review results for these claims will not be included in Cycle 1 claim approval rates.
For more information on the resumption of RCD, click visit the CMS website.
We value your opinion and want to provide the highest-quality and most relevant Medicare knowledge possible. Please let us know if this article was helpful.
It didn't answer my question
This article was helpful
We’re glad we could help you today and appreciate your feedback. When you rate our articles as most helpful, we know that we are on the right track for providing you with important news and information.
We're sorry this article didn't help you today. We'll use your feedback to review this article to try to revise or expand it. Contact us with more feedback or a question on this topic.
Last Updated: 08/13/2020
We've recently uppgraded our website and it looks you're trying to access an old link. Please select an option below.
Attempt to load this page on new site
Go to Home page
Go to Contact Us page
View a related article: